High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group Smita Bhatia, Yutaka Yasui, Leslie L. Robison, Jillian M. Birch, Monica K. Bogue, Lisa Diller, Cyndi DeLaat, Franca Fossati-Bellani, Elaine Morgan, Odile Oberlin, Gregory Reaman, Frederick B. Ruymann, Jean Tersak, Anna T. Meadows From the City of Hope National Medical Center, Duarte, CA; University of Minnesota, Minneapolis, MN; Royal Manchester Children’s Hospital, Manchester, England; Dana-Farber Cancer Institute, Boston, MA; Istituto Nazionale Tumori, Milan, Italy; Institut Gustave-Roussy, Villejuif, France; Columbus Children’s Hospital, Columbus; Children’s Hospital Medical Center, Cincinnati, OH; Children’s Memorial Hospital, Chicago, IL; Children’s National Medical Center, Washington, DC; Children’s Hospital of Pittsburgh; and Children’s Hospital of Philadelphia, PA. Address reprint requests to Smita Bhatia, MD, MPH, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010-3000; e-mail: sbhatia@coh.org. Purpose: We present an update of a previously reported Late Effects Study Group cohort of 1,380 children with Hodgkin’s disease (HD) diagnosed between 1955 and 1986 in patients aged 16 years or younger. We describe the pattern and incidence of subsequent neoplasms (SNs) occurring with extended follow-up. Patients and Methods: Median age at diagnosis of HD was 11.7 years (range, 0.3 to 16.9 years) and at last follow-up was 27.8 years. Median length of follow-up was 17.0 years. Results: An additional 103 SNs were ascertained (total SNs = 212). The cohort was at an 18.5-fold increased risk of developing SNs compared with the general population (standardized incidence ratio [SIR], 18.5, 95% CI, 15.6 to 21.7). The cumulative incidence of any second malignancy was 10.6% at 20 years, increasing to 26.3% at 30 years; and of solid malignancies was 7.3% at 20 years, increasing to 23.5% at 30 years. Breast cancer was the most common solid malignancy (SIR, 56.7). Other commonly occurring solid malignancies included thyroid cancer (SIR, 36.4), bone tumors (SIR, 37.1), and colorectal (SIR, 36.4), lung (SIR, 27.3), and gastric cancers (SIR, 63.9). Risk factors for solid tumors included young age at HD and radiation-based therapy. Thirty-two patients developed third neoplasms, with the cumulative incidence approaching 21% at 10 years from diagnosis of second malignancy. Conclusion: Additional follow-up of this large cohort of HD survivors documents an increasing occurrence of known radiation-associated solid tumors, (breast and thyroid cancers), as well as emergence of epithelial neoplasms common in adults, (colon and lung cancers) at a younger age than expected in the general population, necessitating ongoing surveillance of this high risk population. Presented in part at the 43rd Annual Meeting of the American Society of Hematology, Orlando, FL, December 7–11, 2001. Journal of Clinical Oncology, Vol 21, Issue 23 (December), 2003: 4386-4394 Abstract #1067 SABCS 2006 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.